Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats

  • Jeong, Hye-Jin (Department of Nutritional Science and Food Management, Ewha Womans University) ;
  • Kwon, Hye-Jin (Department of Nutritional Science and Food Management, Ewha Womans University) ;
  • Kim, Mi-Kyung (Department of Nutritional Science and Food Management, Ewha Womans University)
  • Published : 2009.03.31

Abstract

The aim of this study was to examine the hypoglycemic effect of chlorella in 6 week-old type 2 diabetic Goto-Kakizaki (GK, n=30) rats and 6 week-old normal Wistar (n=30) rats. Animals were randomly assigned to 3 groups respectively, and were fed three different experimental diets containing 0%, 3% or 5% (w/w) chlorella for 8 weeks. In diabetic GK rats, the insulinogenic-indices were not significantly different among the groups. The concentrations of fasting plasma glucagon and hepatic triglyceride, and the insulin/glucagon ratios of the GK-3% chlorella and GK-5% chlorella groups were significantly lower than those of the GK-control group. The HOMA-index and the concentrations of fasting blood glucose and plasma insulin of the GK-3% chlorella and GK-5% chlorella groups were slightly lower than those of the GK-control group. In normal Wistar rats, the insulinogenic-indices were not significantly different among the normal groups, but that of the Wistar-5% chlorella group was slightly higher than the other groups. The concentrations of fasting blood glucose and plasma insulin, and the HOMA-index of the Wistar-5% chlorella group were a little higher, and the fasting plasma glucagon concentration and the insulin/glucagon ratio of the Wistar-5% chlorella group were significantly higher than those of the Wistar-control and Wistar-3% chlorella groups. In conclusion, this study shows that the glucose-stimulated insulin secretion was not affected by the intake of chlorella, which could be beneficial, however, in improving insulin sensitivity in type 2 diabetic GK and normal Wistar rats.

References

  1. Asano T, Yoshida R, Ogata H, Kokawa K, Ogimoto M, Akehi Y, Anzai K, Ono J, Tamura K, Hidehira K & Kikuchi M (2007). Beta-Cell Function is a Major Contributor to Oral Glucose Disposition in Obese Japanese Students. Endocr J 54:903-910 https://doi.org/10.1507/endocrj.K07-016
  2. Bernard P (2005). Programmed disorders of $\beta$-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 21:495-504 https://doi.org/10.1002/dmrr.566
  3. Bligh EG & Dyer WJ (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917 https://doi.org/10.1139/y59-099
  4. Boden G, Chen X & Iqbal N (1998). Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes 47:1609-1612 https://doi.org/10.2337/diabetes.47.10.1609
  5. Briones M & Bajaj M (2006). Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus. Expert Opin Pharmacother 7:1055-1064 https://doi.org/10.1517/14656566.7.8.1055
  6. Chen MS, Kao CS & Chang CJ (1991). Prevalence and risk factors of diabetic retinopathy among non-insulin-dependent diabetic subjects. Am J Ophthalmol 114:723-730
  7. Cherng JY & Shih MF (2005a). Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. Life Sci 77:980-990 https://doi.org/10.1016/j.lfs.2004.12.036
  8. Cherng JY & Shih MF (2005b). Preventing dyslipidemia by chlorella pyrenoidosa in rats and hamster after chronic high fat diet treatment. Life Sci 76:3001-3013 https://doi.org/10.1016/j.lfs.2004.10.055
  9. Cherng JY & Shih MF (2006). Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci 78:1181-1186 https://doi.org/10.1016/j.lfs.2005.06.050
  10. Choi KH, Song KH, Lee SH, Chung SH, Kin EJ, Ko SH, Kwon HS, Ahn YB, Yoon KH, Cha BY, Lee KW, Son HY & Kang SK (2004). Relative hyperglucagonemia and its related factors in patients with type 2 diabetes. The Journal of the Korean Diabetes Association 28:338-345
  11. Egan JM, Clocquet AR & Elahi D (2002). The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab 87:1282-1290 https://doi.org/10.1210/jc.87.3.1282
  12. Fanelli CG, Porcellati F, Rossetti P & Bolli GB (2006). Glucagon: The effects of its excess and deficiency on insulin action. Nutr Metab Cardiovasc Dis 16:S28-S34 https://doi.org/10.1016/j.numecd.2005.10.018
  13. Ferrannini E, Muscelli E, Natali A, Gabriel R, Mitrakou A, Flyvbjerg A & Golay A, Hojlund k and Relationship between Insulin Sensitivity and Cardiovascular Disease Risk (RISC) Project Investigators (2007). Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia 50:2342-2347 https://doi.org/10.1007/s00125-007-0806-x
  14. Fossati P & Prencipe L (1982). Serum glycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080
  15. Haffner SM, Lehto S, Ronnemaa T, Pyorala K & Laakso M (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234 https://doi.org/10.1056/NEJM199807233390404
  16. Han JG, Kang GG, Kim JK & Kim SH (2002). The present status and future of chlorella. Food Science and Industry 6:64-69
  17. Harris MI, Hadden WC, Knowler WC & Bennett PH (1987). Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36:523-534 https://doi.org/10.2337/diabetes.36.4.523
  18. Jiang G & Zhang BB (2003). Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284:E671-E678 https://doi.org/10.1152/ajpendo.00492.2002
  19. Jue Li, Takashi Kaneko, Li-Qiang Qin, Jing Wang, Yuan Wang & and Akio Sato (2003). Long-term effects of high dietary fiber intake on glucose tolerance and lipid metabolism in GK rats: Comparison among Barley, Rise and Cornstarch. Metabolism 53: 1206-1210 https://doi.org/10.1016/S0026-0495(03)00159-8
  20. Kang MS, SIm AJ & Chae HJ (2004). Chlorella as a functional biomaterial. Korean J Biotechnol Bioeng 19:1-11
  21. Keen H (1986). What’s in a name? IDDM/NIDDM. Type 1/type 2. Diabet Med 3:11-12 https://doi.org/10.1111/j.1464-5491.1986.tb00697.x
  22. Kim MK & Paek JE (1997). Effect of dietary fibers in rice and barely on lipid and cadmium metabolism in the rat. The Korean Journal of Nutrition 26:21-33
  23. Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y & Baron AD (2002). Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 88:3082-3089 https://doi.org/10.1210/jc.2002-021545
  24. Layne E (1957). Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol 3:447-454 https://doi.org/10.1016/S0076-6879(57)03413-8
  25. Mahler RJ & Adler ML (1999). Type 2 diabetes mellitus : update on diagnosis, pathophysiology, and treatment. J Clin Endocrinol Metab 84:1165-1171 https://doi.org/10.1210/jc.84.4.1165
  26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA & Treacher DF (1985). Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 https://doi.org/10.1007/BF00280883
  27. McGowan MW, Artiss JD, Strandbergh DR & Zak B (1983). A peroxidase-coupled method for colorimetric determination of serum triglycerides. Clin Chem 29:538-542
  28. Ministry of Health and Welfare (1999). Report on 1998 National Health and Nutrition Survey: Nutrition Survey, Seoul. Republic of Korea
  29. Ministry of Health and Welfare (2006). Report on 2005 National Health and Nutrition Survey: Nutrition Survey, Seoul. Republic of Korea
  30. Nunes E, Peixoto F, Louro T, Sena CM, Santos MS, Matafome P, Moreira PI & Seica R (2007). Soybean oil treatment impairs glucose-stimulated insulin secretion and changes fatty acid composition of normal and diabetic islets. Acta Diabetol 44:121-130 https://doi.org/10.1007/s00592-007-0252-8
  31. Nutrition Research Council (1995). Nutrient requirements of laboratory animals. The academy press., Seoul. Republic of Korea
  32. Park SM (2007). Strategies for development of anti-diabetic functional foods. Food Science and Industry 40:46-58
  33. Pratley RE & Weyer C (2002). The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44:929-945 https://doi.org/10.1007/s001250100580
  34. Reaven GM, Chang H, Ho H, Jeng CY & Hoffman BB (1988). Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am J Physiol 254:E23-E30
  35. Reeves PG, Nielsen FH & Fahey GC (1993). AIN-93 purified diets for laboratory rodent : Final report of the American Institute Nutrition Ad Hoc wrighting Committee on the reformulation of the AIN-79A rodent diet. J Nutr 123:1939-1951 https://doi.org/10.1093/jn/123.11.1939
  36. Reitman A & Frankel S (1957). A colorimetric method for the determination of serum glutamic oxaloacetatic and glutamic pyruvic transaminase. Am J Clin Pathol 28:56-63 https://doi.org/10.1093/ajcp/28.1.56
  37. Rhee BD (2003). Epidemiological characteristics of diabetes mellitus among korean population. The Journal of the Korean Diabetes Association 27:173-178
  38. Roden M, Price PB, Perseghin G, Petersen KF. Pothman DL, Cline GW & Shulman GI (1996). Mechanism of free fatty acid-induced insulin resistance in human. J Clin Invest 97:2859-2865 https://doi.org/10.1172/JCI118742
  39. Rodiriguez-Lopez M (1964). Action of the chlorella pyrenoidosa on experimental diabetes in rats. Med Exp Int J Exp Med 10:381-386 https://doi.org/10.1159/000135443
  40. Rodriguez-Lopez M & Lopez-Quijada C (1971). Plasma-glucose and plasma-insulin in normal and alloxanized rats treated with Chlorella. Life Sci 10:57-60 https://doi.org/10.1016/0024-3205(71)90225-6
  41. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen MR & Groop L (1991). Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:409-415 https://doi.org/10.1007/BF00403179
  42. Sano T, Kumamoto Y, Kamiya N, Okuda M & Tanaka Y (1988). Effect of lipophilic extract on Chlorella vulgaris on alimentary hyperlipidemia in cholesterol-fed rats. Artery 15:217-224
  43. Simonson GD & Kendalla DM (2005). Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus. Coron Artery Dis 16:465-472 https://doi.org/10.1097/00019501-200512000-00002
  44. Smith C, Marks AD & Lieberman M (2005). Basic medical biochemistry, p.478-479. Lippincott Williams & Wilkins., Baltimore. USA
  45. Song KE, Kim DJ, Park JW, Cho HK, Lee KW & Huh KB (2007). Clinical characteristics of Korean type 2 diabetic patients according to insulin secretion and insulin resistance. The Journal of the Korean Diabetes Association 31:123-129 https://doi.org/10.4093/jkda.2007.31.2.123
  46. The Koreas Society of Food Science and Nutrition (2000). Handbook of experiments in food science and nutrition, p.661. Hyoil Press., Seoul. Republic of Korea
  47. Unger RH (1978). Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 27:1691-1709 https://doi.org/10.1016/0026-0495(78)90291-3
  48. Wakasugi K (1989). Glucagon degrading activity. Nippon Naibunpi Gakkai Zasshi 65:483-496
  49. Webster D, Bignell AH & Attwood EC (1974). An assessment of the suitability of bromocresol green for the determination of serum albumin. Clin Chim Acta 53:101-108 https://doi.org/10.1016/0009-8981(74)90357-X
  50. Wild S, Roglic G, Green A, Sicree R & King H (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 https://doi.org/10.2337/diacare.27.5.1047